The briefing
New research is testing whether metformin, physical activity, and GLP-1 medications can reduce lung cancer risks driven by obesity. Investigators report ongoing trials and emerging human data aimed at expanding preventive strategies.
Original headline
Expanding the Evidence on Lung Cancer Prevention